摘要
目的:分析治疗体表静脉畸形(Venous malformations,VM)中,DSA联合超声引导的应用价值。方法:选择2020年4月~2023年12月收治的132例体表VM患者进行研究,均给予直接经皮穿刺注射硬化剂,以治疗方式的不同分组,参照组(n=66)以单纯超声引导下治疗,研究组(n=66)以DSA联合超声引导治疗,针对治疗效果和不良反应及生活质量进行对比。结果:治疗效果研究组明显高于参照组,具有统计学差异(P<0.05);比较治疗前生活质量,两组比较无统计学差异(P>0.05),治疗后具有统计学差异(P<0.05),研究组更高;不良反应比较研究组较参照组低,两组具有统计学差异(P<0.05)。结论:体表静脉畸形患者经DSA联合超声引导下治疗取得满意疗效,并且不良反应发生率低,促进生活质量提高。
Objective:To investigate the application value of DSA combined with ultrasound guidance in the treatment of superficial venous malformations(VM).Methods:A study was conducted on 132 patients with superficial VMs admitted from April 2020 to December 2023,all of whom were treated with direct percutaneous injection of sclerosing agents.Treatment methods were divided into different groups.The reference group(n=66)was treated with simple ultrasound guidance,while the study group(n=66)was treated with DSA combined with ultrasound guidance.The treatment effects,adverse reactions,and quality of life were compared.Results:The therapeutic effect of the study group was significantly higher than that of the reference group,with a difference(P<0.05);The quality of life before treatment was compared between the two groups,with P>0.05.There was a difference after treatment(P<0.05),and the study group had a higher quality of life;The adverse reactions in the study group were lower than those in the reference group,and there was a statistically significant difference between the two groups(P<0.05).Conclusion:Patients with superficial venous malformations have achieved satisfactory therapeutic effects through DSA combined with ultrasound-guided treatment,and the incidence of adverse reactions is low,which promotes the improvement of quality of life.
作者
郭仪林
李茂
任邡
潘金
曾先敏
田旭东
彭丹
GUO Yi-lin;LI Mao;REN Fang;PAN Jin;ZENG Xian-min;TIAN Xu-dong;PENG Dan(Vascular Surgery,Guiyang Maitong Vascular Hospital,Guizhou Guiyang 550001)
出处
《中国医疗器械信息》
2024年第18期4-6,共3页
China Medical Device Information
关键词
体表静脉畸形
数字减影血管造影
超声
superficial venous malformation
digital silhouette angiography
ultrasonic
